VYCOR MEDICAL INC financial data

Symbol
VYCO on OTC
Location
Boca Raton,, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 13% % -11%
Quick Ratio 3.6% % -29%
Debt-to-equity -124% % 3.4%
Return On Equity 0.43% % -92%
Return On Assets -1.8% % 91%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 33,372,796 shares 0%
Common Stock, Shares, Outstanding 33,372,796 shares 0%
Entity Public Float $1,101,551 USD -6.2%
Common Stock, Value, Issued $3,347 USD -0.03%
Weighted Average Number of Shares Outstanding, Basic 33,372,796 shares 1.4%
Weighted Average Number of Shares Outstanding, Diluted 33,372,796 shares 1.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $1,901,749 USD 32%
Research and Development Expense $4,201 USD 86%
Operating Income (Loss) $89,769 USD
Nonoperating Income (Expense) $104,265 USD -6.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $14,496 USD 92%
Net Income (Loss) Attributable to Parent $16,477 USD 91%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $64,230 USD -59%
Accounts Receivable, after Allowance for Credit Loss, Current $326,052 USD 37%
Inventory, Net $167,415 USD -11%
Assets, Current $662,596 USD -11%
Property, Plant and Equipment, Net $148,474 USD -29%
Operating Lease, Right-of-Use Asset $67,615 USD -41%
Assets $941,195 USD -12%
Accounts Payable, Current $92,821 USD -39%
Accrued Liabilities, Current $127,231 USD
Liabilities, Current $4,815,077 USD 5.8%
Operating Lease, Liability, Noncurrent $13,566 USD -79%
Liabilities $4,965,388 USD 4.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax $127,677 USD 0%
Retained Earnings (Accumulated Deficit) $33,586,170 USD -1%
Stockholders' Equity Attributable to Parent $4,024,193 USD -9.3%
Liabilities and Equity $941,195 USD -12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $26,909 USD -1526%
Net Cash Provided by (Used in) Financing Activities $17,690 USD -11%
Net Cash Provided by (Used in) Investing Activities $662 USD 130%
Common Stock, Shares Authorized 55,000,000 shares 0%
Common Stock, Shares, Issued 33,476,130 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $44,599 USD -232%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,233 USD 63%
Deferred Tax Assets, Valuation Allowance $4,642,000 USD -0.41%
Operating Lease, Liability $64,745 USD -42%
Depreciation $16,110 USD 3.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $16,477 USD 91%
Property, Plant and Equipment, Gross $1,402,796 USD 0.3%
Operating Lease, Liability, Current $51,179 USD 8.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two $53,655 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $52,092 USD 1%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $29,431,959 USD 0%
Share-based Payment Arrangement, Expense $2,364 USD -67%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%